← Leaderboards
Jialiang Wang
Massachusetts General Hospital
$672,669
Attributed
$672,669
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $341.8K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$672,669 · 2
By mechanism
R00$486,909 · 1
K99$185,760 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Sylvie Breton$16,832,550
- Schahram Akbarian$48,610,378
- Paola Pajevic Divieti$9,923,104
- Henry M Kronenberg$26,229,120
- Dennis Brown$23,445,948
Others in their field
Other Rising Stars on “Affect”
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Brian Todd Schaneberg · Illinois Institute Of Technology$13,469,813
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
AffectApplications GrantsAwardBioinformaticsBiologyBoneBone DevelopmentBone DiseasesBone HealthBone ResorptionBrainCareerCell Culture TechniquesCellsCell Surface ExtensionsCell TypeCommunicationComplexDendritesEnsureEtiologyFacultyFutureAcceleration
Grant awards (4)
Comprehensive investigation of SP7 during the osteoblast-to-osteocyte transition$238,024
R00 · FY2025 · AR · contact PI
Comprehensive investigation of SP7 during the osteoblast-to-osteocyte transition$248,885
R00 · FY2024 · AR · contact PI
Comprehensive investigation of SP7 during the osteoblast-to-osteocyte transition$92,880
K99 · FY2024 · AR · contact PI
Comprehensive investigation of SP7 during the osteoblast-to-osteocyte transition$92,880
K99 · FY2023 · AR · contact PI